Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3709589018 | Product containing dihydroergotamine in nasal dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3709590010 | Dihydroergotamine-containing product in nasal dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dihydroergotamine-containing product in nasal dose form | Plays role | Antimigraine therapeutic role | true | Inferred relationship | Some | ||
| Dihydroergotamine-containing product in nasal dose form | Has active ingredient | Dihydroergotamine | true | Inferred relationship | Some | 1 | |
| Dihydroergotamine-containing product in nasal dose form | Is a | Product manufactured as nasal dose form | true | Inferred relationship | Some | ||
| Dihydroergotamine-containing product in nasal dose form | Is a | Dihydroergotamine-containing product | true | Inferred relationship | Some | ||
| Dihydroergotamine-containing product in nasal dose form | Has manufactured dose form | Nasal dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Dihydroergotamine only product in nasal dose form | Is a | True | Dihydroergotamine-containing product in nasal dose form | Inferred relationship | Some | |
| Dihydroergotamine mesylate 4mg/1mL nasal spray | Is a | False | Dihydroergotamine-containing product in nasal dose form | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
FHIR